Victory Capital Management Inc Taysha Gene Therapies, Inc. Transaction History
Victory Capital Management Inc
- $99 Billion
- Q3 2024
A detailed history of Victory Capital Management Inc transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 20,007 shares of TSHA stock, worth $45,415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,007
Previous 18,062
10.77%
Holding current value
$45,415
Previous $40,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TSHA
# of Institutions
120Shares Held
136MCall Options Held
25.9KPut Options Held
24K-
Avoro Capital Advisors LLC New York, NY18.7MShares$42.3 Million0.56% of portfolio
-
Rtw Investments, LP New York, NY14.9MShares$33.9 Million0.48% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$26.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$24.7 Million0.3% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$20.4 Million1.87% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $110M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...